Medicare Enrolled
Dr. Elizabeth Guancial, MD
Hematology · Sarasota, FL
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Guancial from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Guancial?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Guancial
Dr. Elizabeth Guancial is a hematology specialist in Sarasota, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Guancial performed 182,498 Medicare services in 2023. These records do not provide a deduplicated patient total.
Between the years covered by Open Payments, Dr. Guancial received a total of $6,906 from 42 pharmaceutical and/or device companies across 206 payment records. A record can group multiple payments. These transfers are publicly reported through CMS Open Payments. Disclosure alone does not establish their effect on care. A reliable breakdown by payment category is not available in this snapshot. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Guancial is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 19 years of NPI registration
▲ Top 27% volume in FL
$6,906 industry payments
Florida License Status
FL DOH · MQA1
Active license
None
Board action on record
0
Recent admin complaints
| Profession | License # | Status | Expires | Board Action |
|---|---|---|---|---|
| Medical Doctor | 135035 | Clear | January 31, 2028 | — |
Data from Florida Department of Health Medical Quality Assurance.
License records are public under Chapter 119, Florida Statutes.
Verify directly on FL DOH →
Medicare Practice Summary — 2023
Medicare Utilization ↗182,498
Medicare services
Top 27% in FL for hematology
Not available
Unique patients (not deduplicated)
$15
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Paclitaxel chemotherapy injection | 33,572 | $0 | $2 |
| Nivolumab injection (Opdivo) | 32,040 | $24 | $72 |
| Pembrolizumab injection (Keytruda) | 27,000 | $43 | $137 |
| Iron infusion (Feraheme) An injection of ferumoxytol used to treat iron deficiency anemia in patients not on dialysis. |
24,990 | $0 | $4 |
| Anti-nausea injection (aprepitant) | 22,620 | $1 | $5 |
| Denosumab injection (Prolia/Xgeva) | 6,840 | $18 | $51 |
| Epoetin alfa injection (Procrit) for anemia An injection of epoetin alfa containing 1000 units for use in patients not on end-stage renal disease (ESRD) dialysis. |
6,010 | $6 | $23 |
| Dexamethasone injection (steroid) An injection of dexamethasone sodium phosphate, a corticosteroid medication, administered in a dose of 1 milligram. |
5,485 | $0 | $3 |
| Anti-nausea injection (Aloxi/palonosetron) | 3,140 | $1 | $28 |
| Eflapegrastim injection, 0.1 mg An injection of eflapegrastim-xnst administered at a dose of 0.1 mg. |
2,904 | $26 | $116 |
| Immune globulin infusion (Gammagard) An injection of immune globulin (Gammagard Liquid) to provide antibodies. The dose specified is 500 mg. |
2,760 | $36 | $108 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,957 | $8 | $9 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,936 | $8 | $29 |
| Anti-nausea injection (ondansetron/Zofran) | 1,656 | $0 | $9 |
| Intravenous injection of additional new drug or substance Administration of an additional new medication or substance directly into a vein. |
1,279 | $12 | $61 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,212 | $94 | $339 |
| Carboplatin chemotherapy injection, 50 mg Administration of a 50 mg dose of carboplatin, a chemotherapy medication, via injection. |
983 | $2 | $41 |
| Intravenous chemotherapy infusion, 1 hour or less Administration of chemotherapy medication directly into a vein. The procedure takes one hour or less to complete. |
857 | $96 | $378 |
| Drug injection, under skin or into muscle A procedure involving the administration of a medication or substance via injection into the subcutaneous tissue or muscle. |
449 | $10 | $69 |
| Leuprolide acetate (for depot suspension), 7.5 mg | 433 | $136 | $562 |
| Injection, gemcitabine hydrochloride, not otherwise specified, 200 mg | 416 | $3 | $205 |
| Zoledronic acid injection, 1 mg An injection of zoledronic acid administered at a dose of 1 mg. |
383 | $7 | $69 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
373 | $65 | $239 |
| Diphenhydramine injection, up to 50 mg An injection of diphenhydramine hydrochloride, an antihistamine medication, administered in a dose of up to 50 milligrams. |
362 | $1 | $3 |
| Additional hour of intravenous chemotherapy This code represents the administration of chemotherapy medication into a vein for each additional hour beyond the initial period. |
306 | $21 | $79 |
| Intravenous infusion of new drug or substance, 1 hour or less This procedure involves administering a new medication or substance directly into a vein through an existing access site. The infusion is completed within one hour or less. |
299 | $49 | $178 |
| Additional sequential IV infusion, 1 hour or less This code represents an additional intravenous infusion administered sequentially to a primary infusion. It covers the administration time of one hour or less. |
248 | $22 | $84 |
| Intravenous infusion, 1 hour or less Administration of medication or fluid directly into a vein for therapeutic, preventive, or diagnostic purposes. The procedure lasts one hour or less. |
226 | $46 | $189 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
216 | $133 | $474 |
| Additional hour of intravenous hydration This code represents each additional hour of intravenous fluid administration beyond the initial hour. It is used to bill for extended hydration therapy. |
204 | $10 | $42 |
| Subcutaneous or intramuscular chemotherapy injection This procedure involves administering anti-cancer hormonal medication through an injection into the tissue under the skin or into a muscle. |
176 | $24 | $89 |
| Injection, leuprolide acetate for depot suspension (cipla), 7.5 mg | 135 | $305 | $1,210 |
| Normal saline infusion, 1000 cc Administration of 1000 cc of normal saline solution into a vein. This procedure involves the intravenous delivery of a sterile saltwater solution. |
125 | $2 | $7 |
| Office visit for established patient An office visit for an existing patient that may not require the healthcare professional to be present. |
119 | $16 | $59 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
116 | $2 | $8 |
| New patient office visit, complex (60-74 min) | 105 | $156 | $585 |
| Additional hour of intravenous infusion This code represents each additional hour of intravenous infusion beyond the initial hour for therapy, prevention, or diagnosis. |
96 | $15 | $56 |
| Intravenous drug injection A procedure involving the administration of a medication or substance directly into a vein. |
81 | $27 | $156 |
| Methylprednisolone injection, up to 40 mg An injection of methylprednisolone sodium succinate, a corticosteroid medication, administered in a dose of up to 40 mg. |
80 | $3 | $11 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
60 | $52 | $206 |
| Automated red blood cell count with calculations A blood test that automatically counts red blood cells and performs additional calculations to assess blood health. |
47 | $5 | $20 |
| Vitamin B-12 injection An injection of vitamin B-12 (cyanocobalamin) with a dose of up to 1000 mcg. |
47 | $1 | $6 |
| Normal saline infusion, 500 ml Administration of sterile normal saline solution through an intravenous line. This procedure involves the infusion of a 500 ml unit of the solution. |
35 | $1 | $7 |
| Intravenous push injection of new drug or substance A healthcare provider injects a new medication or substance directly into a vein using a push technique. |
33 | $42 | $170 |
| Injection, lorazepam, 2 mg | 31 | $1 | $2 |
| Intravenous hydration infusion, 31-60 minutes Administration of fluids into a vein to maintain hydration. This procedure involves an infusion lasting between 31 and 60 minutes. |
23 | $25 | $156 |
| New patient office visit (30-44 min) An initial office visit for a new patient lasting between 30 and 44 minutes. This code is used when the total time spent on the date of the encounter falls within this range. |
18 | $88 | $298 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
15 | $94 | $453 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. These counts do not measure clinical quality or years of experience.
16.3% high complexity
80.0% medium
3.7% routine
Industry Payment Transparency
Open Payments through 2024 ↗$6,906
Total received (2018-2024)
Avg $1,151/year across 6 years
Bottom 48% in FL for hematology
42
Companies
206
Payment records
Payments are publicly reported; disclosure does not establish legality · Not evidence of wrongdoing · How to interpret →
Payment categories are unavailable while the source breakdown is being rebuilt. Company and year totals do not identify how much belongs to each category.
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$471
2023
$724
2022
$332
2020
$271
2019
$1,242
2018
$3,865
Payments by company (2024)
TAIHO ONCOLOGY, INC.
$84
Gilead Sciences, Inc.
$63
E.R. Squibb & Sons, L.L.C.
$54
Dendreon Pharmaceuticals LLC
$52
ABBVIE INC.
$52
PFIZER INC.
$33
ARRAY BIOPHARMA INC
$31
Celgene Corporation
$28
Mirati Therapeutics, Inc.
$19
Janssen Biotech, Inc.
$17
Eisai Inc.
$16
Exelixis Inc.
$16
Veracyte, Inc.
$5
Top 3 companies account for 42.7% of 2024 payments
All-time payments by company (2018-2024) ›
Genentech USA, Inc.
$3,198
Merck Sharp & Dohme Corporation
$428
E.R. Squibb & Sons, L.L.C.
$307
Novartis Pharmaceuticals Corporation
$246
GENZYME CORPORATION
$198
AstraZeneca Pharmaceuticals LP
$193
Gilead Sciences, Inc.
$171
PFIZER INC.
$152
Regeneron Healthcare Solutions, Inc.
$139
Celgene Corporation
$130
Incyte Corporation
$111
Lilly USA, LLC
$108
Daiichi Sankyo Inc.
$101
Amgen Inc.
$94
Astellas Pharma US Inc
$92
Dendreon Pharmaceuticals LLC
$89
TAIHO ONCOLOGY, INC.
$84
Janssen Scientific Affairs, LLC
$81
Pharmacyclics LLC, An AbbVie Company
$80
Rigel Pharmaceuticals, Inc.
$77
Exelixis Inc.
$74
Bayer HealthCare Pharmaceuticals Inc.
$73
Janssen Biotech, Inc.
$72
Puma Biotechnology, Inc.
$70
Foundation Medicine, Inc.
$67
Boehringer Ingelheim Pharmaceuticals, Inc.
$64
ABBVIE INC.
$52
Merck Sharp & Dohme LLC
$42
TerSera Therapeutics LLC
$36
Helsinn Therapeutics (U.S.), Inc.
$33
Mirati Therapeutics, Inc.
$33
Array BioPharma Inc.
$31
ARRAY BIOPHARMA INC
$31
EMD Serono, Inc.
$28
Agios Pharmaceuticals, Inc.
$25
G1 Therapeutics, Inc.
$18
CTI BioPharma Corp.
$18
Eisai Inc.
$16
EISAI INC.
$13
ADC Therapeutics America, Inc.
$13
NanoString Technologies, Inc.
$12
Veracyte, Inc.
$5
Top 3 companies account for 57.0% of all-time payments
Associated products mentioned in payments ›
AKYNZEO · ALIMTA · Alecensa · Aliqopa · BOSULIF · Balversa · Bavencio · Braftovi · CABOMETYX · CALQUENCE · COSELA · CYRAMZA · Cabometyx · DARZALEX · ELITEK · EMPLICITI · EPKINLY · ERLEADA · Enhertu · Erleada · FOUNDATIONONE · GILOTRIF · Halaven · IBRANCE · IMBRUVICA · JAKAFI · JEVTANA · KEYTRUDA · KRAZATI · Kyprolis · LENVIMA · LIBTAYO · LIBTAYO CEMIPLIMAB-RWLC INJECTION · LONSURF · LORBRENA · LYNPARZA · Lenvima · MEKINIST · MONJUVI · Nerlynx · Neulasta · Nplate · ONUREG · OPDIVO · OPDUALAG · PADCEV · PIQRAY · PLUVICTO · PROMACTA · PROSIGNA ASSAY · PROVENGE · Padcev · Perjeta · REBLOZYL · RETACRIT · Rezlidhia · TASIGNA · TECENTRIQ · TIBSOVO · TIVDAK · Tavalisse · Trodelvy · VENCLEXTA · VERZENIO · VOTRIENT · Vonjo · XALKORI · XOSPATA · XTANDI · Xofigo · ZOLADEX
Should you be concerned? Industry payments are disclosed through CMS Open Payments. Disclosure alone does not establish their purpose, legality, or effect on care. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Geographic Context
Hematologists in nearby ZIP areas
20
County median income
$80,633
Nearest hospital to ZIP centroid (approximate)
SARASOTA MEMORIAL HOSPITAL
2.6 mi
2.6 mi
Data Sources
| Provider Registry | ✓ NPPES | NPPES snapshot; verify current record |
| Medicare Enrollment | ✓ PECOS | PECOS snapshot |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not included | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →
Summary
Dr. Guancial is a mixed practice specialist, with above-average Medicare volume (top 27% in FL), with 19 years of NPI registration.
This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →
Frequently Asked Questions
Is Dr. Guancial experienced with paclitaxel chemotherapy injection?
Based on Medicare claims data, Dr. Guancial performed 33,572 paclitaxel chemotherapy injection services. These records cover Medicare fee-for-service activity, including eligible younger beneficiaries; they do not measure total practice volume or clinical quality.
Does Dr. Guancial receive payments from pharmaceutical companies?
Yes. Dr. Guancial received a total of $6,906 from 42 companies across 206 payment records. A record can group multiple payments. These transfers are publicly disclosed through CMS Open Payments. Disclosure alone does not establish their legality or effect on care. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Guancial's costs compare to other hematologists in Sarasota?
Dr. Guancial's average Medicare payment per service is $15. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Guancial) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating the presence of registry, enrollment, activity or payment records, not verified experience or clinical quality. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Source publication dates and the snapshots loaded on this site can differ. Rebuilding a page does not refresh its source records. Check the Medicare reporting year and the payment interval shown above; consult the linked official sources for newer releases and current registry details. See our data freshness policy →
Explore related providers
Same specialty & city
Hematologists in Sarasota
Browse hematologists in Sarasota ranked by procedure volume and transparency data.
Highest volume
Top Hematologists in FL
Hematologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Hematologists in FL
Which FL hematologists receive the most from drug and device companies.
By company
Genentech USA, Inc. Payments to Doctors
See all physicians who received payments from Genentech USA, Inc.
By company
Merck Sharp & Dohme Corporation Payments to Doctors
See all physicians who received payments from Merck Sharp & Dohme Corporation.
By company
E.R. Squibb & Sons, L.L.C. Payments to Doctors
See all physicians who received payments from E.R. Squibb & Sons, L.L.C.
About this page
This page combines public CMS records with calculated summaries and explanatory procedure labels. These transformations are not verbatim federal records. Sources: NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology